Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 15, 2016 - Issue 4
Submit an article Journal homepage
1,013
Views
11
CrossRef citations to date
0
Altmetric
Meta-Opinion

Switching long acting antipsychotic medications to aripiprazole long acting once-a-month: expert consensus by a panel of Italian and Spanish psychiatrists

Andrea FagioliniDepartment of Mental Health and Deparment of Molecular Medicine, University of Siena Medical Center, Siena, ItalyCorrespondence[email protected]
,
Emilia AlfonsiDepartment of Mental Health, National Health Service, Ancona, Italy
,
Giovanni AmodeoDepartment of Mental Health and Deparment of Molecular Medicine, University of Siena Medical Center, Siena, Italy
,
Mario CenciDepartment of Mental Health, Fabriano, Italy
,
Michele Di LellaDepartment of Mental Health, National Health Service, Alessandria, Italy
,
Francesco FarinellaDepartment of Mental Health, National Health Service, Catania, Italy
,
Fabrizio FerraiuoloDepartment of Mental Health, National Health Service, Caserta, Italy
,
David FraguasDepartment of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, CIBERSAM, IiSGM, Madrid, Spain
,
Natale LoparcoDepartment of Mental Health, National Health Service, Taranto, Italy
,
Luis Gutierrez-RojasDepartamento de Psiquiatría, Hospital Clínico, Granada - Complejo Hospitalario Granada, Granada, Spain
,
Maria Laura MignoneDepartment of Mental Health, National Health Service, Salerno, Italy
,
Giuseppe PataracchiaDepartment of Mental Health, National Health Service, Recanati-Macerata, Italy
,
Gianluca PillaiDepartment of Mental Health, National Health Service, Oristano, Italy
,
Felicia RussoServizio Psichiatrico di Diagnosi e Cura, Ospedale F. Fallacara, Triggiano and Department of Mental Health, National Health Service, Bari, Italy
,
Vanessa Sanchez-GistauEarly Intervention Psychosis Service, Hospital Universitari Insitut Pere Mata, IISPV, Universitat Rovira i Virgili, CIBERSAM, Reus, Spain
,
Franco SpinogattiDepartment of Mental Health, National Health Service, Cremona, Italy
,
Marco ToscanoDepartment of Mental Health, ASST Rhodense, Garbagnate M.se, Italy
,
Vincenzo VillariDepartment of Mental Health, National Health Service, Torino, Italy
&
Sergio De FilippisCasa di Cura Neuropsichiatrica e Comunità Terapeutica-Genzano, University of Rome and Villa Von Siebenthal, Rome, Italy
 show all
Pages 449-455 | Received 23 Jan 2016, Accepted 15 Feb 2016, Published online: 09 Mar 2016

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Ning Ma, Lei Zhang, Wufang Zhang, Yingying He, Chong Ye & Xin Li. (2023) Long-Acting Injectable Antipsychotic Treatment for Schizophrenia in Asian Population: A Scoping Review. Neuropsychiatric Disease and Treatment 19, pages 1987-2006.
Read now
Juan Carlos García Álvarez, Luz González Sánchez, Eloy García Resa, José María Bonete Llácer, Ana Román Rodríguez, Beatriz Pecino Esquerdo & Enrique Pérez Martínez. (2020) Clinical evolution of patients treated with aripiprazole long-acting injectable: a preliminary, prospective, observational study. International Journal of Psychiatry in Clinical Practice 24:1, pages 10-17.
Read now
Rosaria Di Lorenzo, Paola Ferri, Michela Cameli, Sergio Rovesti & Chiara Piemonte. (2019) Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting. Neuropsychiatric Disease and Treatment 15, pages 183-198.
Read now
Martha Sajatovic, Ruth Ross, Susan N Legacy, Matthew Byerly, John M Kane, Faith DiBiasi, Heather Fitzgerald & Christoph U Correll. (2018) Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2. Neuropsychiatric Disease and Treatment 14, pages 1475-1492.
Read now
Giovanni Amodeo, Chiara Candiracci, Ilaria Capecci, Sergio De Filippis, Sonia Giuliani, Giorgio Guerani, Carmine Tomasetti, Vincenzo Villari & Andrea Fagiolini. (2016) Starting aripiprazole long-acting-once-a-month early in treatment: why, how and for whom? Expert consensus and practical recommendations by a panel of Italian clinicians. Expert Opinion on Pharmacotherapy 17:16, pages 2143-2147.
Read now

Articles from other publishers (6)

Chih-Sung Liang, Tung-Ping Su, Ming-Hsien Hsieh, Chau-Shoun Lee, Joseph Kuo, Nan-Ying Chiu, Po-See Chen, Yung-Chieh Yen & Ya-Mei Bai. (2021) Taiwan Expert Consensus Recommendations for Switching to Aripiprazole Long-Acting Once-Monthly in Patients with Schizophrenia. Journal of Personalized Medicine 11:11, pages 1198.
Crossref
Georgios SchoretsanitisPierre BaumannAndreas ConcaOtto DietmaierGiancarlo GiupponiGerhard GründerMartina HahnXenia HartUrsula Havemann-ReineckeGudrun HefnerMaxim KuzinRainald MössnerDaria PiacentinoWerner SteimerGerald Zernig & Christoph Hiemke. (2021) Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs. Therapeutic Drug Monitoring 43:1, pages 79-102.
Crossref
Michael Ming-Cheuk Wong, Ka-Lok Tam, Eric Yat-Wo Cheung, Chun Lam, Timothy Ming-Hong Yeung, Gloria Fong-Yeung Chan & Ki-Yan Mak. (2020) Consensus statements on aripiprazole once-monthly injectable for Hong Kong. Asian Journal of Psychiatry 54, pages 102394.
Crossref
Jiří Masopust. (2020) Aripiprazole in the form of long-acting intramuscular injections in the clinical practice. Psychiatrie pro praxi 21:1, pages 40-46.
Crossref
Enrico Biagi, Enrico Capuzzi, Fabrizia Colmegna, Alessandra Mascarini, Giulia Brambilla, Alessandra Ornaghi, Jacopo Santambrogio & Massimo Clerici. (2017) Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly. Advances in Therapy 34:5, pages 1036-1048.
Crossref
Yongmin Kim, Sheng-Min Wang, Kyung-Phil Kwak, Ho-Kyoung Yoon, Chi-Un Pae, Jung-Jin Kim & Won-Myong Bahk. (2016) Amisulpride Switching in Schizophrenic Patients Who Showed Suboptimal Effect and/or Tolerability to Current Antipsychotics in a Naturalistic Setting: An Explorative Study. Clinical Psychopharmacology and Neuroscience 14:4, pages 371-377.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.